Choice Hotels International (CHH) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
23 Feb, 2026Executive summary
Adjusted EBITDA reached $626 million in 2025, up 4% year-over-year, with adjusted EPS of $6.94, both in line with guidance.
Record profitability in 2025, with net income of $369.9M, driven by international expansion, higher-revenue brand mix, and growth in the extended stay segment.
Global hotel openings grew 14% year-over-year, with international system size up 13% and U.S. extended stay openings at record levels.
Strategic exits of underperforming hotels improved portfolio quality and are expected to support positive U.S. net rooms growth in 2026.
Awarded 22% more global franchise agreements in 2025, with significant growth in both U.S. and international markets.
Financial highlights
Total revenues for 2025 were $1.60B, up slightly from $1.59B in 2024; Q4 revenues were flat at $390M.
Fourth quarter 2025 revenues (excluding reimbursables) rose 2% year-over-year to $234 million; adjusted EBITDA was $141 million; adjusted EPS up 3% to $1.60.
Net income for 2025 was $370M, up from $300M in 2024; Q4 net income was $64M, down from $76M in Q4 2024.
Partnership revenues grew 14% year-over-year, with 16% growth in Q4, driven by co-brand and supplier fees.
U.S. royalty rate expanded to 5.14% for 2025; average royalty rate increased 8 basis points in 2025 and 10 basis points in Q4.
Outlook and guidance
2026 adjusted EBITDA expected between $632 million and $647 million; adjusted EPS guidance of $6.92–$7.14.
Net global rooms growth projected at ~1% year-over-year, with U.S. net rooms growth returning to positive territory.
Global and U.S. RevPAR growth expected to range from -2% to 1% year-over-year.
Average royalty rate and adjusted SG&A both expected to grow in the mid-single digits.
Net hotel development outlays for 2026 expected at $20–$45 million, down 70% from 2025.
Latest events from Choice Hotels International
- Double-digit profit and room growth in 2024, with strong 2025 earnings and pipeline outlook.CHH
Q4 202423 Feb 2026 - Record Q2 results, global pipeline up 22%, and 2024 EPS guidance raised.CHH
Q2 20242 Feb 2026 - Record Q3 earnings, raised 2024 outlook, and robust global pipeline growth.CHH
Q3 202417 Jan 2026 - Strong 2024 results, new incentive plan, and support for simple majority voting highlighted.CHH
Proxy Filing1 Dec 2025 - Abstentions and broker non-votes will not count for or against key proposals at the annual meeting.CHH
Proxy Filing1 Dec 2025 - Record adjusted EBITDA and EPS, strong international and extended stay growth, and Canadian expansion.CHH
Q2 202523 Nov 2025 - Board, compensation, and incentive plans approved amid strong financial and brand growth.CHH
AGM 202520 Nov 2025 - Record Q1 profit, EBITDA, and RevPAR growth support a strong long-term outlook.CHH
Q1 202519 Nov 2025 - Record Q3 2025 EBITDA and net income driven by global growth and a major Canada acquisition.CHH
Q3 202513 Nov 2025